NCC Angel Grants has supported relief and research programs related to children’s cancers and diseases, so that children have the treatments that they need today, as well as hope for tomorrow’s cures.

Our largest support within the Angel Grants program is that of access to modern FDA approved specialty and biological medicines to pediatric patients all over the world that require these medicines. Throughout the world, children with serious chronic diseases are not able to access the leading and proven therapies to properly treat their illnesses. These medicines often require refrigeration and special handling, for which NCC has developed experience and expertise. NCC partners with global manufacturers of innovative therapies to create access of life-saving drugs for pediatric patients with cancer, hemophilia, and enzyme deficiency diseases. The patients that we target are poor who would otherwise not receive these medicines.

The Angel Grants program also seeks to provide seed funding to scientific researchers who are developing innovative treatments that could potentially benefit children suffering with cancer. As treatment becomes more specific in its approach, NCC recognizes that support of personalized medicine research is much needed and we support this important field that we anticipate will lead the charge for clinical breakthroughs.